The relationship between obesity, metabolic syndrome and thyroid pathology
O. V. Kosareva,
S. V. Bulgakova,
Yu. A. Dolgikh,
L. A. Sharonova,
P. Ya. Merzlova,
E. V. Treneva,
D. P. Kurmaev https://doi.org/10.31146/1682-8658-ecg-235-3-177-182
Abstract
Obesity is a pressing medical and social problem for all countries, including the Russian Federation. Obesity is the main component of metabolic syndrome and aggravates the course of many diseases, including endocrine ones. Obesity is a pressing medical and social problem for all countries, including the Russian Federation. Obesity is the main component of metabolic syndrome and aggravates the course of many diseases, including endocrine ones. It can be both a cause and a consequence of pathological processes. The article presents data on the effect of obesity on thyroid function. The relationship between adipose tissue and thyroid hormones is shown. The connection between obesity and hypothyroidism - overt and subclinical, autoimmune thyroiditis - is discussed. The issues of the relationship between the components of metabolic syndrome and thyroid function are considered. Weight loss was shown to improve thyroid function.
About the Authors
O. V. Kosareva
Samara State Medical University
Russian Federation
Russian Federation
S. V. Bulgakova
Samara State Medical University
Russian Federation
Russian Federation
Yu. A. Dolgikh
Samara State Medical University
Russian Federation
Russian Federation
L. A. Sharonova
Samara State Medical University
Russian Federation
Russian Federation
P. Ya. Merzlova
Samara State Medical University
Russian Federation
Russian Federation
E. V. Treneva
Samara State Medical University
Russian Federation
Russian Federation
D. P. Kurmaev
Samara State Medical University
Russian Federation
Russian Federation
References
1. (WHO (2022), Obesity and overweight, https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
2. (NCD-RisC), N. R. F.C. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population- based measurement studies with 19·2 million participants. The Lancet. 2016;387(10026):1377-1396 doi: 10.1016/S0140-6736(16)30054-X.
3. Balanova Yu.A., Shalnova S.A., Deev A.D., Imaeva A.E., Kontsevaya A.V., Muromtseva G.A., Kapustina А.V., Evstifeeva S.E., Drapkina О.M. Obesity in russian population - prevalence and association with the non-communicable diseases risk factors.Russian Journal of Cardiology. 2018;(6):123-130. (In Russ.) doi: 10.15829/1560-4071-2 018-6-123-130.@@ Баланова Ю.А., Шальнова С.А., Деев А.Д. и соавт. Ожирение в российской популяции - распространенность и ассоциации с факторами риска хронических неинфекционных заболеваний. Российский кардиологический журнал. 2018;23(6):123-130. doi: 10.15829/1560-4071-2 018-6-123-130.
4. Dedov I.I., Mokrysheva N.G., Mel’nichenko G.A. et al. Obesity. Clinical guidelines. Consilium Medicum. 2021; 23 (4): 311-325. (in Russ.) doi: 10.26442/20751753.2021.4.200832.@@ Дедов И.И., Мокрышева Н.Г., Мельниченко Г.А. и соавт. Ожирение. Клинические рекомендации. Consilium Medicum. 2021;23(4):311-325. doi: 10.26442/20751753.2021.4.200832.
5. Fadeev V.V., Morgunova T.B., Melnichenko G.A., Dedov I.I. Draft of the clinical recommendations for diagnosis and treatment of hypothyroidism. Clinical and experimental thyroidology. 2021;17(1):4-13. (In Russ.) doi:10.14341/ket12702.@@ Фадеев В.В., Моргунова Т.Б., Мельниченко Г.А., Дедов И.И. Проект клинических рекомендаций по гипотиреозу. Клиническая и экспериментальная тиреоидология. 2021;17(1):4-13. doi:10.14341/ket12702.
6. Verbovoy A.F., Dolgikh Yu.A., Kosareva O.V. et al. Insulin resistance and thyroid hormones. Pharmateka. 2017.5(338):91-95. (in Russ.) EDN YJBRUD.@@ Вербовой А.Ф., Долгих Ю.А., Косарева О.В. и соавт. Инсулинорезистентность и тиреоидные гормоны. Фарматека. 2017.5(338):91-95. EDN YJBRUD.
7. Sanyal D., Raychaud huri M. Hypothyroidism and obesity: An intriguing link. Indian J Endocrinol Metab. 2016;20(4):554-557. doi:10.4103/2230-8210.183454.
8. Floriani C., Gencer B., Collet T.H., Rodondi N. Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update. Eur Heart J. 2018;39(7):503-507. doi: 10.1093/eurheartj/ehx050.
9. Ruyatkina L.A., Ruyatkin D.S. Subclinical hypothyroidism and metabolic syndrome: reasons for drug intervention. Obesity and metabolism. 2020;17(1):41-47. (In Russ.) doi:10.14341/omet12282.@@ Руяткина Л.А., Руяткин Д.С. Субклинический гипотиреоз и метаболический синдром: основания для медикаментозного вмешательства. Ожирение и метаболизм. 2020;17(1):41-47. doi:10.14341/omet12282.
10. Biondi B., Cappola A.R., Cooper D.S. Subclinical Hypothyroidism: A Review. JAMA. 2019;322(2):153-160. doi: 10.1001/jama.2019.9052
11. Biondi B., Cappola A.R. Subclinical hypothyroidism in older individuals. Lancet Diabetes Endocrinol. 2022;10(2):129-141. doi: 10.1016/S2213-8587(21)00285-0.
12. Razvi S., Jabbar A., Pingitore A. et al. Thyroid Hormones and Cardiovascular Function and Diseases. J Am Coll Cardiol. 2018;71(16):1781-1796. doi: 10.1016/j.jacc.2018.02.045.
13. Duntas L.H., Chiovato L. Cardiovascular Risk in Patients with Subclinical Hypothyroidism. Eur Endocrinol. 2014;10(2):157-160. doi: 10.17925/EE.2014.10.02.157.
14. Mendes D., Alves C., Silverio N., Batel Marques F. Prevalence of Undiagnosed Hypothyroidism in Europe: A Systematic Review and Meta-Analysis. Eur Thyroid J. 2019;8(3):130-143. doi: 10.1159/000499751.
15. Tekle H.A., Bobe T.M., Tufa E.G., Solomon F.B. Age-sex disparities and subclinical hypothyroidism among patients in Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia. J Health Popul Nutr. 2018;37(1):18. doi: 10.1186/s41043-018-0149-x.
16. Siemińska L., Wojciechowska C., Walczak K. et al. Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6. Endokrynol Pol. 2015;66(5):394-403. doi: 10.5603/EP.2015.0049.
17. Chapela S.P., Simancas-Racines A., Ceriani F. et al. Obesity and Obesity-Related Thyroid Dysfunction: Any Potential Role for the Very Low-Calorie Ketogenic Diet (VLCKD)? Curr Nutr Rep. 2024;13(2):194-213. doi: 10.1007/s13668-024-00528-w.
18. Longhi S., Radetti G. Thyroid function and obesity. J Clin Res Pediatr Endocrinol. 2013;5(1):40-44. doi: 10.4274/jcrpe.856.
19. Park S.Y., Park S.E., Jung S.W. et al. Free triiodothyronine/free thyroxine ratio rather than thyrotropin is more associated with metabolic parameters in healthy euthyroid adult subjects. Clin Endocrinol. 2017;87(1):87-96. doi: 10.1111/cen.13345.
20. Mehran L., Amouzegar A., Tohidi M. et al. Serum free thyroxine concentration is associated with metabolic syndrome in euthyroid subjects. Thyroid. 2014;24(11):1566-1574. doi: 10.1089/thy.2014.0103.
21. Chang Y.C., Hua S.C., Chang C.H. et al. High TSH Level within Normal Range Is Associated with Obesity, Dyslipidemia, Hypertension, Inflammation, Hypercoagulability, and the Metabolic Syndrome: A Novel Cardiometabolic Marker. J Clin Med. 2019;8(6). doi: 10.3390/jcm8060817.
22. Deng L., Zheng X., Shuai P., Yu X. Thyroid-Related Hormones Changes Predict Changes in Anthropometric Measures and Incidence of Obesity in Chinese Euthyroid Persons. Horm Metab Res. 2023;55(10):684-691. doi: 10.1055/a-2151-1538.
23. Amouzegar A., Mehran L., Takyar M. et al. Tehran Thyroid Study (TTS).Int J Endocrinol Metab. 2018;16(4): e84727. doi:10.5812/ijem.84727.
24. Mehran L., Amouzegar A., Rahimabad P.K. et al. Thyroid function and metabolic syndrome: A population-based thyroid study. Horm Metab Res. 2017;49(3):192-200. doi: 10.1055/s-0042-117279.
25. Ding X., Zhao Y., Zhu C.Y. et al. The association between subclinical hypothyroidism and metabolic syndrome: an update meta-analysis of observational studies. Endocr J. 2021;68(9):1043-1056. doi: 10.1507/endocrj.EJ20-0796.
26. Alwan H., Ribero V.A., Efthimiou O. et al. A systematic review and meta-analysis investigating the relationship between metabolic syndrome and the incidence of thyroid diseases. Endocrine. 2024;84(2):320-327. doi: 10.1007/s12020-023-03503-7.
27. Wu Z., Jiang Y., Zhou D. et al. Sex-specific Association of Subclinical Hypothyroidism With Incident Metabolic Syndrome: A Population-based Cohort Study. J Clin Endocrinol Metab. 2022;107(6):2365-2372. doi: 10.1210/clinem/dgac110.
28. Mehran L., Amouzegar A., Abdi H. et al. Incidence of Thyroid Dysfunction Facing Metabolic Syndrome: A Prospective Comparative Study with 9 Years of Follow-Up. Eur Thyroid J. 2021;10(5):390-398. doi: 10.1159/000512665.
29. Song R.H., Wang B., Yao Q.M. et al. The Impact of Obesity on Thyroid Autoimmunity and Dysfunction: A Systematic Review and Meta-Analysis. Front Immunol. 2019;10:2349. doi: 10.3389/fimmu.2019.02349.
30. Guo X., He Z., Shao S. et al.Interaction effect of obesity and thyroid autoimmunity on the prevalence of hyperthyrotropinaemia. Endocrine. 2020;68(3):573-583. doi: 10.1007/s12020-020-02236-1.
31. Hino J., Nakatani M., Arai Y. et al. Overexpression of bone morphogenetic protein-3b (BMP-3b) in adipose tissues protects against high-fat diet-induced obesity.Int J Obes (Lond). 2017;41(4):483-488. doi: 10.1038/ijo.2017.15.
32. Lourenço E.V., Liu A., Matarese G., La Cava A. Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation. Proc Natl Acad Sci U S A. 2016;113(38):10637-10642. doi: 10.1073/pnas.1607101113.
33. Abella V., Scotece M., Conde J. et al. Leptin in the interplay of inflammation, metabolism and immune system disorders. Nat Rev Rheumatol. 2017;13(2):100-109. doi: 10.1038/nrrheum.2016.209.
34. Teixeira P.F., Cabral M.D., Silva N.A. et al. Serum leptin in overt and subclinical hypothyroidism: effect of levothyroxine treatment and relationship to menopausal status and body composition. Thyroid. 2009;19(5):443-450. doi: 10.1089/thy.2007.0393.
35. Drobniak A., Kanecki K., Grymowicz M., Radowicki S. Serum leptin concentration in women of reproductive age with euthyroid autoimmune thyroiditis. Gynecol Endocrinol. 2016;32(2):128-131. doi: 10.3109/09513590.2015.1092512.
36. Wang S., Baidoo S.E., Liu Y. et al. T cell-derived leptin contributes to increased frequency of T helper type 17 cells in female patients with Hashimoto’s thyroiditis. Clin Exp Immunol. 2013;171(1):63-68. doi: 10.1111/j.1365-2249.2012.04670.x.
37. Baranowska-Bik A., Bik W. The Association of Obesity with Autoimmune Thyroiditis and Thyroid Function-Possible Mechanisms of Bilateral Interaction.Int J Endocrinol. 2020;14:8894792. doi: 10.1155/2020/8894792.
38. Biondi B. Subclinical Hypothyroidism in Patients with Obesity and Metabolic Syndrome: A Narrative Review. Nutrients. 2023;16(1):87. doi: 10.3390/nu16010087.
Review
For citations:
Kosareva O.V., Bulgakova S.V., Dolgikh Yu.A., Sharonova L.A., Merzlova P.Ya., Treneva E.V., Kurmaev D.P. The relationship between obesity, metabolic syndrome and thyroid pathology. Experimental and Clinical Gastroenterology. 2025;(3):177-182. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-235-3-177-182
Views:
2
Email this article 